91 related articles for article (PubMed ID: 8655273)
41. [The HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
Adachi N; Könü DL; Frei K; Yonekawa Y
No Shinkei Geka; 2000 Oct; 28(10):865-71. PubMed ID: 11070906
[TBL] [Abstract][Full Text] [Related]
42. Novartis licenses gene therapy to avoid monopoly.
Glaser V
Nat Biotechnol; 1997 Feb; 15(2):118-9. PubMed ID: 9035126
[No Abstract] [Full Text] [Related]
43. Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.
Stockhammer G; Brotchi J; Leblanc R; Bernstein M; Schackert G; Weber F; Ostertag C; Mulder NH; Mellstedt H; Seiler R; Yonekawa Y; Twerdy K; Kostron H; De Witte O; Lambermont M; Velu T; Laneuville P; Villemure JG; Rutka JT; Warnke P; Laseur M; Mooij JJ; Boëthius J; Mariani L; Gianella-Borradori A
J Mol Med (Berl); 1997 Apr; 75(4):300-4. PubMed ID: 9151217
[No Abstract] [Full Text] [Related]
44. Gene therapy for glioblastoma.
Aghi M; Chiocca EA
Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
[TBL] [Abstract][Full Text] [Related]
45. Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug.
Kawamura K; Yu L; Tomizawa M; Shimozato O; Ma G; Li Q; Sato A; Yang Y; Suzuki T; Abdel-Aziz NM; Tagawa M
Anticancer Res; 2007; 27(1A):89-93. PubMed ID: 17352220
[TBL] [Abstract][Full Text] [Related]
46. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
[TBL] [Abstract][Full Text] [Related]
47. [Gene therapy for cerebral tumors: use of an adenovirus in the glioma C6 rat model].
Maron A
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):377-80. PubMed ID: 10992887
[TBL] [Abstract][Full Text] [Related]
48. Gene therapy in brain tumours: implications of the size of glioblastoma on its curability.
Izquierdo M; Cortés ML; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Paz JF; Isla A; Blázquez MG
Acta Neurochir Suppl; 1997; 68():111-7. PubMed ID: 9233425
[TBL] [Abstract][Full Text] [Related]
49. Act locally, think globally.
Martuza RL
Nat Med; 1997 Dec; 3(12):1323. PubMed ID: 9396599
[No Abstract] [Full Text] [Related]
50. [Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4)].
Tamiya T; Ohmoto T; Wei MX; Breakfield XO; Chiocca EA
No Shinkei Geka; 1994 Dec; 22(12):1099-110. PubMed ID: 7845504
[No Abstract] [Full Text] [Related]
51. [Gene therapy of malignant brain tumors].
Izquierdo Rojo JM
An R Acad Nac Med (Madr); 1995; 112(3):573-81. PubMed ID: 8579244
[No Abstract] [Full Text] [Related]
52. MRI characteristics and histological changes in glioblastoma after gene therapy.
Weber FW; Floeth FW; Reifenberger G; Felsberg J; Aulich A; Kiwit JC; Bock WJ
Front Radiat Ther Oncol; 1999; 33():244-52. PubMed ID: 10549494
[No Abstract] [Full Text] [Related]
53. Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.
Shir A; Levitzki A
Cell Mol Neurobiol; 2001 Dec; 21(6):645-56. PubMed ID: 12043839
[No Abstract] [Full Text] [Related]
54. Gene therapy.
Gomez-Manzano C; Jiang H; Alonso M; Yung WK; Fueyo J
Handb Clin Neurol; 2012; 104():331-8. PubMed ID: 22230451
[No Abstract] [Full Text] [Related]
55. Gene therapy for cancer.
Blaese RM
Sci Am; 1997 Jun; 276(6):111-5. PubMed ID: 9163943
[No Abstract] [Full Text] [Related]
56. First-in-class antimitotic device approved for glioblastoma.
Oncology (Williston Park); 2011 May; 25(6):546. PubMed ID: 21717911
[No Abstract] [Full Text] [Related]
57. [Gene therapy for brain tumors: its present state of the art and future prospects].
Tabuchi K
No Shinkei Geka; 1994 Sep; 22(9):803-9. PubMed ID: 8090261
[No Abstract] [Full Text] [Related]
58. Ark's gene therapy stumbles at the finish line.
Mitchell P
Nat Biotechnol; 2010 Mar; 28(3):183-4. PubMed ID: 20212462
[No Abstract] [Full Text] [Related]
59. Thymidine kinase: diagnostic and prognostic potential.
O'Neill KL; Buckwalter MR; Murray BK
Expert Rev Mol Diagn; 2001 Nov; 1(4):428-33. PubMed ID: 11901857
[TBL] [Abstract][Full Text] [Related]
60. Tackling the challenges of brain metastases in solid tumors.
Kotecki N; Awada A
Curr Opin Oncol; 2018 Sep; 30(5):330-331. PubMed ID: 30096097
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
